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Introduction
Cardiac magnetic resonance imaging (MRI) is a powerful
imaging technique for a wide range of cardiac problems.
Major disadvantages are high costs and use of resources.
Purpose of the study was to examine the question to what
extent cardiac MRI findings do have relevant conse-
quences for the patient, in relation to the indication.
Methods
590 consecutive cardiac MRIs performed before, during or
after an in-hospital stay in a cardiology department were
scrutinized for indication, findings and the therapeutic
consequences for the patient.
Results
Median age was 60 ± 15 years, 69% of patients were male.
The following main indications occured: ischemia (39%),
myocardial viability alone (7%), accurate left ventricular
function (12%), inflammation/myocarditis (9%), charac-
terisation of a cardiomyopathy (14%), valvular disease
(6%), pulmonary vein anatomy 11%, cardiac mass (2%),
endocarditis, and search for thrombi (1%).
54% of the patients had abnormal findings. In 90% of the
studies there were new findings or a confirmation of a sus-
pected diagnosis could be done. Direct therapeutic conse-
quences in terms of cardiac interventions or surgery
resulted in 39% of all patients. Depending on the indica-
tion the frequency of a following therapy was between
95% (viability) and 20% (myocarditis and cardiomyopa-
thy). In 2% of all studies an abnormal MRI was followed
by an invasive diagnostic procedure without any thera-
peutic consequence due to a false positive test result.
In 12% previously unknown incidental findings were
present: Ventricular thrombi (1.5%), myocardial scars
(2.5%), pericardial effusion (1.9%), atrial septal defect
(0.2%), aortic aneurysm (1.0%), liver cysts (0.8%), pul-
monary infiltrates (3,1%), pleural effusion (0.7%), lym-
phoma (0.3%), liver cirrhosis (0.2%).
Conclusion
In 90% of 590 consecutive cardiac MRI scans in a single
hospital setting a new diagnosis or new findings could be
established. Only in a very small group, MRI caused fur-
ther invasive diagnostics without therapy.
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